Related Experiment Video
Updated: Mar 21, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Downregulation of the TGFβ Pseudoreceptor BAMBI in Non-Small Cell Lung Cancer Enhances TGFβ Signaling and Invasion
Sebastian Marwitz1, Sofia Depner2, Dmytro Dvornikov3
1Pathology of the University Hospital of Lübeck and the Leibniz Research Center Borstel, Borstel, Germany. Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Groβhansdorf, Germany.
Abstract:
Non-small cell lung cancer (NSCLC) is characterized by early metastasis and has the highest mortality rate among all solid tumors, with the majority of patients diagnosed at an advanced stage where curative therapeutic options are lacking. In this study, we identify a targetable mechanism involving TGFβ elevation that orchestrates tumor progression in this disease. Substantial activation of this pathway was detected in human lung cancer tissues with concomitant downregulation of BAMBI, a negative regulator of the TGFβ signaling pathway. Alterations of epithelial-to-mesenchymal transition (EMT) marker expression were observed in lung cancer samples compared with tumor-free tissues. Distinct alterations in the DNA methylation of the gene regions encoding TGFβ pathway components were detected in NSCLC samples compared with tumor-free lung tissues. In particular, epigenetic silencing of BAMBI was identified as a hallmark of NSCLC. Reconstitution of BAMBI expression in NSCLC cells resulted in a marked reduction of TGFβ-induced EMT, migration, and invasion in vitro, along with reduced tumor burden and tumor growth in vivo In conclusion, our results demonstrate how BAMBI downregulation drives the invasiveness of NSCLC, highlighting TGFβ signaling as a candidate therapeutic target in this setting. Cancer Res; 76(13); 3785-801. ©2016 AACR.
Insights
Downregulation of BAMBI, a TGFβ pathway regulator, drives non-small cell lung cancer (NSCLC) invasiveness. Restoring BAMBI reduces tumor growth and metastasis, identifying TGFβ signaling as a potential therapeutic target for NSCLC.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Non-small cell lung cancer (NSCLC) presents significant mortality due to early metastasis and late-stage diagnosis.
- Limited curative options exist for advanced NSCLC, necessitating novel therapeutic targets.
- Tumor progression in NSCLC is often driven by complex signaling pathways.
Purpose of the Study:
- To investigate the role of TGFβ signaling and its regulator BAMBI in NSCLC progression.
- To identify targetable mechanisms contributing to NSCLC invasiveness and metastasis.
- To evaluate the therapeutic potential of restoring BAMBI expression in NSCLC.
Main Methods:
- Analysis of TGFβ pathway activation and BAMBI expression in human NSCLC tissues.
- Assessment of epithelial-to-mesenchymal transition (EMT) markers in NSCLC samples.
- Investigation of DNA methylation patterns in TGFβ pathway genes.
- In vitro and in vivo studies involving BAMBI reconstitution in NSCLC cells.
Main Results:
- Elevated TGFβ signaling and decreased BAMBI expression were observed in NSCLC tissues.
- Alterations in EMT markers and DNA methylation of TGFβ pathway components were detected.
- Epigenetic silencing of BAMBI was identified as a key feature of NSCLC.
- Restoring BAMBI expression inhibited TGFβ-induced EMT, migration, and invasion in vitro, and reduced tumor growth in vivo.
Conclusions:
- BAMBI downregulation is a critical driver of NSCLC invasiveness and metastasis.
- TGFβ signaling represents a promising therapeutic target for NSCLC treatment.
- Restoration of BAMBI function offers a potential strategy to combat NSCLC progression.
More Related Videos
11:06Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System
Published on: July 30, 2018
11:38Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
Related Concept Videos
TGF - β Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Regulation of Angiogenesis and Blood Supply
Intracellular Signaling Affects Focal Adhesions
Some...